Contact Supplier

Contact Supplier

To get in touch with Bachem AG, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    Bachem recognises important Asian market at CPHI Korea

    news-releasesBachem AG
    September 26th 2022

    Bubendorf, Switzerland: –Peptide and Oligonucleotide technology specialist Bachem AG will be a prominent presence at one of Asia’s premier pharma trade expo and networking events, CPHI Korea, returning in rebranded form in Seoul in late September 2022.

    Bachem’s presence in Seoul recognizes the increasing importance of the Korean and South East Asian market to the company and provides a welcome opportunity to renew relationships disrupted by the Covid pandemic.

    Peptide and API portfolio

    Bachem will exhibit from stand G19 at Seoul’s COEX center, showing its extensive portfolio of peptides, oligonucleotides, commercial APIs, cosmetics and research materials.

    It will also make a contribution to the CPHI conference agenda with a presentation on Day Two of the conference from Aya Ito, Business Development Manager at Tokyo-based Bachem K.K. Ms. Ito’s presentation: ‘Why Bachem Is Your Preferred Peptide And Oligonucleotide API Contract Manufacturer’ will be delivered in Seminar Room B as part of Session H-5 (September 29, 1250 hrs).

    Peptide partner

    Aya Ito’s presentation will provide background detail on Bachem as a contract development and manufacturing organization focusing on peptides and oligonucleotides that has developed long-term partnerships with pharmaceutical and biotech companies.

    Aya will also tell the story of Bachem Japan, established in Tokyo in 2018, as well as the strategic move into oligonucleotides, recognizing the increasing market demand for large-scale production of oligomer-based APIs. This has involved investment in new capabilities to manufacture oligonucleotides as well as the development of innovative manufacturing technologies.

    About Bachem

    Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

    Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

    For further information, see www.bachem.com.

    About CPHI Korea 2022

    CPHI Korea is one of Asia’s foremost pharma expos attracting more than 15,000 visitors representing some 25 nations.

    The event is returning from a two-year hiatus due to the COVID pandemic in a rebranded hybrid format blending physical and online dimensions and with a new visual identity.

    CPHI Korea 2022 will be a three day physical event opening September 28 at the COEX exhibition center in Seoul. The online platform will be ‘live’ till October 7. Apart from the CPhI exhibition, the expo will include three other co-located events: ICSE, P-MEC, bioLIVE, and CPHI Korea.

    The event is organized by Informa Markets with further information at:  https://www.cphi.com/korea/en/home.html

    Resources

    Click on Bachem at CPHI Korea 2022 for further information.
    Click on Oligonucleotides – Innovation that transforms lives to watch video.
    Click on Expanding into Oligos: Interview to watch video.
    Click on Bachems News to see latest News & Events.

    TRENDING ARTICLE

    Bachem – Partner from Research to Marketed API

    FREE DOWNLOAD
    Bachem recognises important Asian market at CPHI Korea

    Contact Bachem AG

    Simply fill out the form below to contact Bachem AG now.

    Send Bachem AG a Message